Health-related quality of life and long-term symptoms among patients with non-severe covid-19 – a prospective cohort study. Issue 4 (3rd April 2023)

• Record Type: Journal Article
• Authors: Löfström, Emma; Kunkel, Stefan; Kötz, Arne; Lingman, Markus; Undén, Johan; Nygren, Jens M.
• Is Part Of: Infectious diseases. Volume 55:Issue 4(2023)
• Page Start: 272
• Page End: 281
• Publication Date: 2023-04-03
• Subjects: Covid-19 -- symptoms -- post-covid -- HR-Qol -- perception of illness; Communicable diseases -- Periodicals; Communicable Diseases -- Periodicals; Communicable diseases; Periodicals; 616.9
• DOI: 10.1080/23744235.2023.2175904
• Languages: English
• ISSNs: 2374-4235

Abstract

Abstract: Background: The vast majority of covid-19 patients experience non-severe disease. Nonetheless, long-term symptoms may be common and the impact on quality of life is uncertain. This study aims to examine these aspects in a prospective, longitudinal cohort. Methods: Non-hospitalised patients with PCR-confirmed covid-19 were prospectively invited to self-report assessments of background data, symptoms and recovery, illness perception (BIPQ) and health-related quality of life (HR-Qol) measured by EQ5D-VAS. Results: 154 patients were included (mean age 46 years, 69% female). The majority of participants (65%) had symptoms for 1–4 weeks and 12% more than 6 months. The most common symptoms were initially malaise, fatigue, headache, fever and cough and the most common long-term symptoms were impaired physical condition, fatigue, anosmia and headache. The BIPQ index had a negative correlation with the EQ5D-VAS score after the infection, but not with long-term symptoms. Mean differences in the EQ5D-VAS score were significantly lower after the infection and patients with long-term symptoms had a more pronounced negative effect in EQ5D-VAS scores. Conclusion: We found that most patients with non-severe covid-19 reported symptoms for 1–4 weeks and approximately 10% developed long-term symptoms. Non-severe covid-19 seems to have a negative influence on HR-Qol, especially in patients with long-term symptoms and with a greater burden from the disease. None of the initial symptoms could predict the presence of long-term symptoms.